At a recent panel presentation, several principals of angel groups based in Philadelphia discussed the role of angel groups in funding emerging life science companies, detailing their respective groups' life science investments over the last five years.
The panel included Jeff Nicholas, a partner at Fox Rothschild LLP and the Managing Director of Delaware Crossing, Ellen Edelmen Weber, the Executive Director of Robin Hood Ventures, J. David Owens, an investor in the Mid-Atlantic Angel...